Morgan Stanley analyst Kimberly Greenberger raised the price target on Nike (NYSE: NKE) to $165.00 (from $152.00) while maintaining an Overweight rating.

The analyst commented, "A faster North America wholesale restart, transitory GM benefits, SG&A control, & lean inventory suggest 2Q upside. Valuation nears highs, but NKE’s more promising revenue and margin outlook post-COVID-19 should continue to drive the stock higher. Lift PT to $165."